Lung Cancer

Click on the protocol number to learn more about that clinical trial.

Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-Small Cell Lung Cancer

CALGB 30801

A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer

ECOG E1505

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

ECOG E5508

Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

RTOG 0839

Randomized Phase II Study of Pre-Operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer

RTOG 0937

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

SWOG S0709

Phase II Randomized Study of Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

SWOG S0720

Phase II ERCC 1 and RRM1-Based Adjuvant Therapy Trial in Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

SWOG S0802

Phase II Randomized Study of Topotecan Hydrochloride With Versus Without Aflibercept in Patients With Extensive Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Therapy